Liu, Ping-Yen <br/><br/>
Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study).  [electronic resource] 

 -  PloS one  2013 
 - e76298 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0076298  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticholesteremic Agents--administration & dosage<br/>Atorvastatin<br/>Cholesterol--blood<br/>Coronary Artery Disease--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Female<br/>Heptanoic Acids--administration & dosage<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Hypercholesterolemia--blood<br/>Hypertension--blood<br/>Lipoproteins--blood<br/>Male<br/>Middle Aged<br/>Pyrroles--administration & dosage<br/>Quinolines--administration & dosage<br/>Risk Factors<br/>Treatment Outcome<br/>Triglycerides--blood